Intergroup rhabdomyosarcoma study post-surgical clinical group IIIB: Localized or locally extensive tumor, gross residual disease after major resection (greater than 50 percent debulking)
intergroup rhabdomyosarcoma study post-surgical clinical group iiib: localized or locally extensive tumor, gross residual disease after major resection (greater than 50 percent debulking)
Intergroup rhabdomyosarcoma study post-surgical clinical group IIIB: Localised or locally extensive tumour, gross residual disease after major resection (greater than 50 percent debulking)
intergroup rhabdomyosarcoma study post-surgical clinical group iiib: localised or locally extensive tumour, gross residual disease after major resection (greater than 50 percent debulking)